Does a positive pretransplant crossmatch affect long-term outcome in liver transplantation?

Transplantation

Volumn 91, Issue 3, 2011, Pages 261-262

  Al Sibae, Mohamad R ^a   Koffron, Alan J ^a   Raofi, Vandad ^a  

^a OAKLAND UNIVERSITY   (United States)

Author keywords

Acute rejection; Liver transplantation; Positive crossmatch

Indexed keywords

ACUTE GRAFT REJECTION; ARTICLE; BLOOD GROUP TYPING; GRAFT RECIPIENT; HEPATITIS C VIRUS; IMMUNOSUPPRESSIVE TREATMENT; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; PLASMAPHERESIS; PREOPERATIVE PERIOD; PRIORITY JOURNAL; SENSITIZATION; TREATMENT OUTCOME;

GRAFT REJECTION; HEPATITIS C; HISTOCOMPATIBILITY TESTING; HUMANS; LIVER TRANSPLANTATION; TREATMENT OUTCOME;

EID: 79951514123     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318204758c     Document Type: Article

References (11)

1. Berg CL, Steffick DE, Edwards EB, et al. Liver and intestine transplantation in the United States 1998-2007. Am J Transplant 2009; 9(4 pt 2): 907.
2. Lobo PI, Spencer C, Douglas MT, et al. The lack of long-term detrimental effects on liver allografts caused by donor-specific anti-HLA antibodies. Transplantation 1993; 55: 1063.
3. Doyle HR, Marino IR, Morelli F, et al. Assessing risk in liver transplantation: Special reference to the significance of a positive cytotoxic cross-match. Ann Surg 1996; 224: 168.
4. Iwatsuki S, Rabin BS, Shaw BW Jr, et al. Liver transplantation against T cell-positive warm crossmatches. Transplant Proc 1984; 16: 1427.
5. Raofi V, Shetty K, Mertens S, et al. Positive cross-match predisposes to a higher incidence of acute rejection in liver transplant recipients. Presented as poster at ATC, 2009. Boston, MA; May 2009.
6. Doran TJ, Geczy AF, Painter D, et al. A large, single center investigation of the immunogenetic factors affecting liver transplantation. Transplantation 2000; 69: 1491.
7. Castillo-Rama M, Castro MJ, Bernardo I, et al. Preformed antibodies detected by cytotoxic assay or multibead array decrease liver allograft survival: Role of human leukocyte antigen compatibility. Liver Transpl 2008; 14: 554.
8. Takaya S, Bronsther O, Iwaki Y, et al. The adverse impact on liver transplantation of using positive cytotoxic crossmatch donors. Transplantation 1992; 53: 400.
9. Sheiner PA, Schwartz ME, Mor E, et al. Severe and multiple rejection episodes are associated with early recurrence of hepatitis C after ortho-topic liver transplantation. Hepatology 1995; 21: 30.
10. Rosen HR, Shackleton CR, Higa L, et al. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation. Am J Gastroenterol 1997; 92: 1453.
11. Mañez R, Kelly RH, Kobayashi M, et al. Immunoglobulin G lympho-cytotoxic antibodies in clinical liver transplantation: Studies toward further defining their significance. Hepatology 1995; 21: 1345.